Log In
BCIQ
Print this Print this
 

AXP107-11

  Manage Alerts
Collapse Summary General Information
Company Axcentua Pharmaceuticals AB
DescriptionMultitargeted anticancer compound with chemosensitizing and chemopreventative effects
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPancreatic cancer
Indication DetailsTreat advanced pancreatic cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today